CompoAtlas

AllergieSolution

AllergieSolution, licence 80005007: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
Solution Allergies
Licence holder
Distripharm Inc.
NPN or DIN-HM
80005007
Status
Active licence
Licence date
31 January 2008
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Euphrasia officinalis

Source : Plante(s) entière

7.0 CHNot calculated
Allium cepa

Source : Bulbe

7.0 CHNot calculated
Sabadilla

Source : Graine séchée

7.0 CHNot calculated
Sticta pulmonaria

Source : Thalle en entier

5.0 CHNot calculated

Non-medicinal ingredients

Sucre compressible, Stéarate de magnésium, Dextrose Excipient NF, Sorbitol, Dioxyde de silicium colloïdal

PopulationAgeQuantity per servingFrequency
Adultesminimum: 12.0 Année(s)1.0 Compriméminimum: 3.0 Tous les jours ; maximum: 4.0 Tous les jours

Uses authorised in Canada

Allergies/Fièvre des foins est un médicament homéopathique recommandé pour le soulager les symptômes des allergies et de la fièvre des foins : larmoiement, éternuement, écoulement nasal, toux, obstruction nasale, maux de tête.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80005007

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line